课题基金 / 基金详情

EVALUATION OF HIV GAG DNA VACCINE TO MAX T HELPER/CTL

EVALUATION OF HIV GAG DNA VACCINE TO MAX T HELPER/CTL
HIV GAG DNA 疫苗对 MAX T Helper/CTL 的评估
批准号:
6021285
负责人:
Xiao-Fang Yu
金额:
$28.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-15 至 2002-06-30

项目摘要

项目成果

Xiao-Fang Yu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) Our overall goal is to determine the mechanisms by which CD8+ cytotoxic T lymphocyte (CTL) and CD4+ T helper responses can be elicited against highly conserved internal virion proteins of HIV-1 Gag. Toward this goal, a novel development is the construction of DNA expression vectors, which enable us to express Gag in a Rev and RRE independent and species independent fashion. Using this new method, we will systematically evaluate the expression of, and immune response to, different subcellularly targeted forms of HIV-1 Gag to maximize the induction of CTL and T helper responses against Gag in mice. We will carry out two specific aims: (1). Characterization of the ability of various HIV-1 Gag expression vectors to induce CD8+ CTL. HIV-1 Gag expression vectors which enable us to express HIV-1 Gag molecules in mouse cells in the absence of Rev and RRE have been generated. Derivative Gag expression vectors, which are targeted to different intracellular and extracellular compartments for antigen processing and presentation will be constructed and evaluated. These different forms of Gag include: (a) wild type Gag that assembles into particles which are released from cells efficiently; (b) mutant Gags that fail to target to plasma membrane and remain in the cytoplasm; (c) mutant Gags that fail to assemble into particles; (d) mutant Gags that are rapidly degraded intracellularly, (e) secreted but non-particle forms of Gag; (f) cell surface anchored forms of Gag. (A) Various forms of HIV-11 Gag molecules will be expressed in p815 cells and compared as CTL target cells. (B) DNA vectors expressing various forms of HIV-1 Gag molecules will be tested for CTL induction in mice. (2). Characterization of the ability of various HIV-1 Gag expression vectors that will optimize T helper response especially those that could enhance CTL response. (A) The different forms of HIVA Gag DNA vaccine described above will also be evaluated for induction of T helper responses after DNA immunization in mice by measuring T cell proliferative and cytokine responses after Gag stimulation in vitro. (B) A CTLA-4-HIV-1 Gag fusion molecule encoded by a single DNA vaccine vector will be evaluated. This strategy will allow specific targeting of Gag molecules to antigen presentation cells for MHC class 11 presentation. (C) Combination studies by using DNA vectors identified from this specific aim with DNA vectors identified from specific aim 1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of novel anti-HIV inhibitors based on Vif-E3 activity
  • 批准号:
    8467123
  • 项目类别:
  • 资助金额:
    $22.84万
  • 财政年份:
    2013
  • 负责人:
    Xiao-Fang Yu
  • 依托单位:
Identification and characterization of novel anti-HIV inhibitors
  • 批准号:
    8132453
  • 项目类别:
  • 资助金额:
    $20.3万
  • 财政年份:
    2010
  • 负责人:
    Xiao-Fang Yu
  • 依托单位:
Identification and characterization of novel anti-HIV inhibitors
  • 批准号:
    8012537
  • 项目类别:
  • 资助金额:
    $24.6万
  • 财政年份:
    2010
  • 负责人:
    Xiao-Fang Yu
  • 依托单位:
Novel Small Molecule Inhibitors of HIV
  • 批准号:
    7895567
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2009
  • 负责人:
    Xiao-Fang Yu
  • 依托单位:
海外基金